ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
X4 Pharmaceuticals Inc

X4 Pharmaceuticals Inc (XFOR)

0.5472
0.0355
( 6.94% )
Updated: 04:28:28

X4 Pharmaceuticals Inc Financial Summary

The current XFOR market cap is 92.2M. The company's latest EPS is USD -0.6004 and P/E is -0.92.

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0000563k
Operating Income -25.81M-27.21M-25.2M-37.29M-33.9M
Net Income -55.71M-2.31M-19.13M-51.77M90.83M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 03M000
Operating Income -47.8M-59.87M-85.11M-88.08M-107.52M
Net Income -53.4M-62.13M-102.64M-96.41M-101.17M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 173.4M173.29M147.26M112.18M210.61M
Total Liabilities 105.86M105.7M96.16M111.15M116.16M
Total Equity 67.54M67.59M51.1M1.04M94.45M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 160.7M122.87M117.18M155.59M147.26M
Total Liabilities 31.48M50.07M52.76M81.54M96.16M
Total Equity 129.22M72.8M64.41M74.05M51.1M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -47.94M-68.77M-96.51M-33.6M-63.87M
Investing -4.89M-10.05M-14.88M-5.32M98.54M
Financing 67.21M88.42M88.52M N/A 20.16M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -48.06M-58.82M-70.91M-77.1M-96.51M
Investing 27.23M-1.36M-615k-103k-14.88M
Financing 140.66M12.39M74.25M117.23M88.52M
Market Cap 92.2M
Price to Earnings Ratio -0.92
Price to Sales Ratio 0
Price to Cash Ratio 0.93
Price to Book Ratio 1.81
Dividend Yield -

Share Statistics

Shares Outstanding 168.5M
Average Volume (1 week) 2.02M
Average Volume (1 Month) 1.09M
52 Week Change -39.27%
52 Week High 1.60
52 Week Low 0.4721
Spread (Intraday) 0 (0.64%)

Company Info

Company Name X4 Pharmaceuticals Inc
Address 3411 silverside road tatnall
wilmington, delaware 19810
Website https://www.x4pharma.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock